The University of Chicago Header Logo

Connection

Gini Fleming to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Gini Fleming has written about Clinical Trials as Topic.
Gini Fleming
Connection Strength
0.806
Clinical Trials as Topic
  1. Therapeutic Targets and Opportunities in Endometrial Cancer: Update on Endocrine Therapy and Nonimmunotherapy Targeted Options. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-11.
    View in: PubMed
    Score: 0.125
  2. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. J Clin Oncol. 2017 Sep 20; 35(27):3113-3122.
    View in: PubMed
    Score: 0.104
  3. Second-Line Therapy for Endometrial Cancer: The Need for Better Options. J Clin Oncol. 2015 Nov 01; 33(31):3535-40.
    View in: PubMed
    Score: 0.091
  4. New drugs in ovarian cancer. Clin Adv Hematol Oncol. 2015 Apr; 13(4):223-5.
    View in: PubMed
    Score: 0.089
  5. Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials. J Natl Cancer Inst. 2013 Jul 03; 105(13):954-9.
    View in: PubMed
    Score: 0.078
  6. Current treatment of metastatic endometrial cancer. Cancer Control. 2009 Jan; 16(1):38-45.
    View in: PubMed
    Score: 0.058
  7. Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant. J Clin Oncol. 2007 Jul 10; 25(20):2983-90.
    View in: PubMed
    Score: 0.052
  8. Adjuvant aromatase inhibitors: are we there yet? Cancer. 2003 Nov 01; 98(9):1779-81.
    View in: PubMed
    Score: 0.040
  9. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol. 2003 Jun 15; 21(12):2268-75.
    View in: PubMed
    Score: 0.039
  10. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer. 2002 Sep 01; 95(5):989-96.
    View in: PubMed
    Score: 0.037
  11. Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows. J Clin Oncol. 2019 04 10; 37(11):862-866.
    View in: PubMed
    Score: 0.029
  12. Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials. J Clin Oncol. 2016 07 01; 34(19):2221-31.
    View in: PubMed
    Score: 0.024
  13. Nanomedicine for Combination Therapy of Cancer. EBioMedicine. 2015 May; 2(5):366-7.
    View in: PubMed
    Score: 0.022
  14. Antifolates: the next generation. Semin Oncol. 1992 Dec; 19(6):707-19.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.